Ignite Creation Date:
2025-12-25 @ 2:29 AM
Ignite Modification Date:
2025-12-27 @ 12:48 PM
Study NCT ID:
NCT02186834
Status:
COMPLETED
Last Update Posted:
2023-01-04
First Post:
2014-07-08
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Selinexor (KPT-330) and Liposomal Doxorubicin For Relapsed and Refractory Multiple Myeloma
Sponsor:
H. Lee Moffitt Cancer Center and Research Institute
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-09-23
Start Date Type:
ACTUAL
Primary Completion Date:
2017-11-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-03-14
Completion Date Type:
ACTUAL
First Submit Date:
2014-07-08
First Submit QC Date:
None
Study First Post Date:
2014-07-10
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2018-08-30
Results First Submit QC Date:
None
Results First Post Date:
2019-02-19
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-12-29
Last Update Post Date:
2023-01-04
Last Update Post Date Type:
ACTUAL